MSFT 453.9631 -2.6353% AAPL 228.225 -2.0409% NVDA 131.2 -2.75% GOOGL 187.56 -1.8935% GOOG 189.16 -1.8167% AMZN 196.37 -1.7118% META 522.38 -2.3023% AVGO 1714.64 -1.7224% TSLA 265.3951 0.811% TSM 187.5 -1.8582% LLY 937.8 -0.2107% V 261.56 -0.5475% JPM 207.67 -0.0626% UNH 505.78 0.9682% NVO 141.2 -1.0789% WMT 69.41 -1.4203% LVMUY 154.5 1.9667% XOM 112.96 0.9292% LVMHF 770.5 1.6491% MA 432.89 -0.173%

UnitedHealth Group Incorporated

Healthcare US UNH


Last update at 2024-07-11T14:52:00Z

Day Range


52 Week Range



  • Previous Close 500.93
  • Market Cap481247.72M
  • Volume822960
  • P/E Ratio22.57
  • Dividend Yield1.45%
  • EBITDA34540.00M
  • Revenue TTM359982.01M
  • Revenue Per Share TTM386.66
  • Gross Profit TTM 79617.00M
  • Diluted EPS TTM23.05


Income Statement


Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 26343.00M 22310.00M 20742.00M 17981.00M 15944.00M
Minority interest -519.00000M -447.00000M 366.00M 400.00M 396.00M
Net income 20120.00M 17285.00M 15403.00M 13839.00M 11986.00M
Selling general administrative 47782.00M 42579.00M 41704.00M 35193.00M 34074.00M
Selling and marketing expenses - - - - -
Gross profit 77587.00M 67328.00M 65498.00M 55712.00M 52470.00M
Reconciled depreciation 3400.00M 3103.00M 2891.00M 2720.00M 2428.00M
Ebit 28435.00M 23970.00M 22405.00M 19685.00M 15968.00M
Ebitda 29805.00M 24749.00M 23794.00M 20519.00M 18396.00M
Depreciation and amortization 1370.00M 779.00M 1389.00M 834.00M 2428.00M
Non operating income net other - - - - -
Operating income 28435.00M 23970.00M 22405.00M 19685.00M 17344.00M
Other operating expenses 295727.00M 263627.00M 234736.00M 222470.00M 208903.00M
Interest expense 2092.00M 1660.00M 1663.00M 1704.00M 1400.00M
Tax provision 5704.00M 4578.00M 4973.00M 3742.00M 3562.00M
Interest income 2092.00M 1660.00M 1663.00M 1704.00M 1400.00M
Net interest income -2092.00000M -1660.00000M -1663.00000M -1704.00000M -1400.00000M
Extraordinary items - - - 0.00000M 0.00000M
Non recurring - - - - -
Other items - - - - -
Income tax expense 5704.00M 4578.00M 4973.00M 3742.00M 3562.00M
Total revenue 322132.00M 285273.00M 255639.00M 240269.00M 224871.00M
Total operating expenses 51182.00M 45682.00M 44595.00M 37913.00M 36502.00M
Cost of revenue 244545.00M 217945.00M 190141.00M 184557.00M 172401.00M
Total other income expense net -2092.00000M -1660.00000M -1663.00000M -1704.00000M 1376.00M
Discontinued operations - - - - -
Net income from continuing ops 20639.00M 17732.00M 15769.00M 14239.00M 12382.00M
Net income applicable to common shares 20120.00M 17285.00M 15403.00M 13839.00M 11986.00M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 245705.00M 212206.00M 197289.00M 173889.00M 152221.00M
Intangible assets 14401.00M 10044.00M 10856.00M 10349.00M 9325.00M
Earning assets - - - - -
Other current assets 23477.00M 23635.00M 21067.00M 16567.00M 12980.00M
Total liab 159358.00M 135727.00M 126750.00M 111727.00M 95994.00M
Total stockholder equity 81450.00M 75045.00M 68328.00M 60436.00M 54319.00M
Deferred long term liab 2769.00M 3265.00M 3367.00M 2993.00M 2474.00M
Other current liab 53996.00M 47618.00M 42887.00M 33600.00M 28949.00M
Common stock 9.00M 10.00M 10.00M 9.00M 10.00M
Capital stock 9.00M 10.00M 10.00M 9.00M 10.00M
Retained earnings 86156.00M 77134.00M 69295.00M 61178.00M 55846.00M
Other liab 11775.00M 15052.00M 15682.00M 9982.00M 8204.00M
Good will 93352.00M 75795.00M 71337.00M 65659.00M 58910.00M
Other assets 20714.00M 107334.00M 52752.00M 13810.00M 8346.00M
Cash 23365.00M 21375.00M 16921.00M 10985.00M 10866.00M
Cash and equivalents 27911.00M 21375.00M 16921.00M 10985.00M 10866.00M
Total current liabilities 89237.00M 78292.00M 72420.00M 61782.00M 53209.00M
Current deferred revenue 3075.00M 2571.00M 2842.00M 2622.00M 2396.00M
Net debt 34258.00M 24628.00M 26546.00M 29693.00M 25688.00M
Short term debt 3110.00M 3620.00M 4819.00M 3870.00M 1973.00M
Short long term debt 3110.00M 3620.00M 4819.00M 3870.00M 1973.00M
Short long term debt total 57623.00M 46003.00M 43467.00M 40678.00M 36554.00M
Other stockholder equity 3678.00M 3285.00M 2837.00M 2827.00M 2623.00M
Property plant equipment 10128.00M 8969.00M 8626.00M 8704.00M 8458.00M
Total current assets 69069.00M 61758.00M 53718.00M 42634.00M 38692.00M
Long term investments 43728.00M 43114.00M 41242.00M 37209.00M 32510.00M
Net tangible assets -25084.00000M 75045.00M -14491.00000M -16666.00000M -14631.00000M
Short term investments 4546.00M 2532.00M 2860.00M 3260.00M 3458.00M
Net receivables 17681.00M 14216.00M 12870.00M 11822.00M 11388.00M
Long term debt 54513.00M 42383.00M 38648.00M 36808.00M 34581.00M
Inventory - - - - -
Accounts payable 29056.00M 24483.00M 21872.00M 21690.00M 19891.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity 3678.00M 3285.00M 2837.00M 2820.00M 2623.00M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -8393.00000M -5384.00000M -3814.00000M -3578.00000M -4160.00000M
Additional paid in capital - - - - -
Common stock total equity 9.00M 10.00M 10.00M 9.00M 10.00M
Preferred stock total equity - - - - -
Retained earnings total equity 86156.00M 77134.00M 69295.00M 61178.00M 55846.00M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 12258.00M 107334.00M 102329.00M 94046.00M 1852.00M
Deferred long term asset charges - - - - -
Non current assets total 176636.00M 150448.00M 143571.00M 131255.00M 113529.00M
Capital lease obligations - - - - -
Long term debt total 54513.00M 42383.00M 38648.00M 36808.00M 34581.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -28476.00000M -1843.00000M -2836.00000M -2504.00000M -4099.00000M
Change to liabilities 6143.00M -3553.00000M 5778.00M 2084.00M 2395.00M
Total cashflows from investing activities -28476.00000M -10372.00000M -12532.00000M -12699.00000M -12385.00000M
Net borrowings 12536.00M 2481.00M 2586.00M 3994.00M 4134.00M
Total cash from financing activities 4226.00M -7455.00000M -3590.00000M -5625.00000M -4365.00000M
Change to operating activities 2679.00M 1522.00M 2895.00M -342.00000M 1081.00M
Net income 20639.00M 17732.00M 15769.00M 14239.00M 12382.00M
Change in cash 1990.00M 4454.00M 5936.00M 119.00M -1115.00000M
Begin period cash flow 21375.00M 16921.00M 10985.00M 10866.00M 11981.00M
End period cash flow 23365.00M 21375.00M 16921.00M 10985.00M 10866.00M
Total cash from operating activities 26206.00M 22343.00M 22174.00M 18463.00M 15713.00M
Issuance of capital stock 1253.00M 1355.00M 1440.00M 1037.00M 838.00M
Depreciation 3400.00M 3103.00M 2891.00M 2720.00M 2428.00M
Other cashflows from investing activities -25674.00000M -1254.00000M -7645.00000M -8124.00000M -6223.00000M
Dividends paid -5991.00000M -5280.00000M -4584.00000M -3932.00000M 3320.00M
Change to inventory - -1031.00000M -2195.00000M -1563.00000M -750.00000M
Change to account receivables -2523.00000M -1000.00000M -688.00000M 162.00M -1351.00000M
Sale purchase of stock -7000.00000M -5000.00000M -4250.00000M -5500.00000M -4500.00000M
Other cashflows from financing activities 18979.00M 4620.00M 6954.00M 4520.00M 5418.00M
Change to netincome -79.00000M 433.00M 619.00M 821.00M 609.00M
Capital expenditures 2802.00M 2454.00M 2051.00M 2071.00M 2063.00M
Change receivables -2523.00000M 1000.00M -688.00000M 162.00M -1351.00000M
Cash flows other operating -1374.00000M 1031.00M -2195.00000M -1563.00000M -750.00000M
Exchange rate changes - -62.00000M -116.00000M -20.00000M -78.00000M
Cash and cash equivalents changes 1956.00M -40232.00000M 5936.00M 119.00M -1115.00000M
Change in working capital 2246.00M 1522.00M 2895.00M 683.00M 294.00M
Stock based compensation 925.00M 800.00M 679.00M 697.00M 638.00M
Other non cash items 673.00M -944.00000M -52.00000M 294.00M 325.00M
Free cash flow 23404.00M 19889.00M 20123.00M 16392.00M 13650.00M

Peer Comparison

Sector: Healthcare Industry: Healthcare Plans

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
UnitedHealth Group Incorporated
4.85 0.97% 505.78 22.57 18.38 1.33 5.65 1.38 13.97
Elevance Health Inc
-2.01 0.38% 532.58 18.00 12.66 0.65 2.87 0.74
CVS Health Corp
0.63 1.10% 58.16 12.06 9.08 0.29 1.34 0.47 8.96
Cigna Corp
1.02 0.31% 330.93 16.80 10.45 0.46 1.90 0.58
Humana Inc
3.52 0.93% 382.69 19.16 14.60 0.56 3.37 0.53

Reports Covered

Stock Research & News


UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The OptumHealth segment provides care delivery, care management, wellness and consumer engagement, and health financial services for consumers, care delivery systems, providers, employers, payers, and public-sector entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.

UnitedHealth Group Incorporated

UnitedHealth Group Center, Minnetonka, MN, United States, 55343

Key Executives

Name Title Year Born
Sir Andrew Philip Witty CEO & Director 1965
Mr. Dirk C. McMahon Pres & COO 1960
Mr. John F. Rex Exec. VP & CFO 1962
Mr. Brian Robert Thompson Exec. VP & CEO of UnitedHealthcare NA
Mr. Thomas Edward Roos Sr. VP & Chief Accounting Officer 1973
Mr. Sandeep Dadlani Exec. VP and Chief Digital & Technology Officer 1975
Mr. Zachary William Sopcak Sr. VP of Capital Markets Communications & Investor Relations NA
Mr. Rupert Bondy Exec. VP & Chief Legal Officer 1962
Ms. Jennifer Mound Smoter Sr. VP & Chief Communications Officer NA
Mr. James T. Barry Jr. Director of Sales for Western Pennsylvania 1946

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.